ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 222722 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 222722; 2) Community: the network communities that were significantly associated with the response to NSC 222722; 3) Molecule: the relationships between components within communities and NSC 222722; 4) MDR: the compounds that were significantly associated with the NSC 222722.

NSC Compound Enrichment Correlation
NSC 740648 5,6-Dihydro-6-(3-imidazolyl-1-propyl)-9-methoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0407060322613564 0.086245698
NSC 744659 6-(chloroethylureidoethyl)diquino-1,4-thiazine 0.0407060322613564 0.21499634
NSC 744677 Null 0.0407060322613564 -0.19085006
NSC 753393 3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0407060322613564 0.13991428
NSC 756133 GSK1007102B 0.0407060322613564 0.057600682
NSC 88971 Null 0.0407060322613564 0.11699328
NSC 752384 Null 0.0407060322613568 -0.17178283
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0462077035966084 0.070970945
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0462077035966084 0.053914379
NSC 176503 Fastigilin B 0.0462077035966084 0.36562655
Total:92  Current:85    [First] [Prev] [Next] [Last]